The term "SAPHO (Synovitis, Acne, Pustulosis, Hyperostosis and Osteitis) syndrome" includes a variety of musculoskeletal disorders associated with skin conditions; Osteitis is the most prominent skeletal lesion, whereas palmoplantar pustulosis and acne are the main skin lesions. Diagnosing SAPHO syndrome is difficult, because this syndrome is often confused with suppurative osteomyelitis, which has similar clinical and pathologic findings. SAPHO diagnosis is even more difficult when atypical sites are involved and there are no skin lesions.
INTRODUCTION
SAPHO (synovitis, acne, pustulosis, hyperostosis and osteitis) syndrome [1] is characterized by osteoarticular and dermatological manifestations. Chamot and co-workers first described in 1987 [2] "le syndrome acne pustulose hyperostose osteite" and introduced the acronym SAPHO, to designate the constellation of these five frequently combined disorders. The syndrome can occur at any age but usually appears between childhood and middle age and follows a prolonged relapsing and remitting course [3] .
Hyperostosis and osteitis are the most prominent SAPHO syndrome findings [4, 5] . Hyperostosis appears radiologically as osteosclerosis, with cortical thickening, narrowing of the medullary canal, and external surface of the bone appearing expanded, indistinct and irregular. Osteitis refers to bone inflammation that appears histopathologically as a sterile inflammatory infiltrate. Bacterial cultures are usually negative [3] , but low virulence microbial agents, such as Propionibacterium acnes (P acnes) have been isolated in deep bone biopsy specimens in a few cases [6] [7] [8] [9] [10] [11] , and Staphylococcus Aureus (S. Aureus) has been isolated from a plantar pustule in one case [12] .
Bone pain and dermatologic manifestations are the most troublesome SAPHO syndrome symptoms [13] . Bony lesions manifest as severe, recurrent, debilitating pain and tenderness. These symptoms can be more severe at night, adversely affect general well-being and can have a major impact on the entire family. Cutaneous manifestations include palmoplantar pustulosis (PPP), severe forms of acne (acne fulminans or conglobrata, hidradenitis suppurativa) and various forms of psoriasis, especially pustular psoriasis [14] .
Because of misdiagnosis or lack of diagnosis, patients with SAPHO syndrome often receive long-term antibiotic therapy combined with surgical procedures, such as saucerisation, decortication, or partial resection of affected bones. However, as SAPHO syndrome etiology and pathophysiology are unknown, these treatment options are complex, uncomfortable, associated with multiple side effects [13, 15] and ineffective in curing the disease [16] [17] [18] . Pain in SAPHO syndrome can be severe and last for several years; therefore early diagnosis is of great importance in order to avoid unnecessary procedures and promptly apply effective treatments.
To our knowledge few studies in the orthopaedic literature discuss osteitis or osteomyelitis in SAPHO syndrome [18] [19] [20] [21] . In this report we describe the clinical, radiographic, and histological findings in five SAPHO syndrome patients. This is an attempt to increase awareness about SAPHO syndrome among Orthopaedic surgeons, so that they recognize it early when they see it. Prompt SAPHO syndrome recognition, followed by appropriate therapy can be remarkably effective, so that ineffective, unnecessary surgical or antibiotic therapies can be avoided.
MATERIALS AND METHODOLOGY
We present data from five patients (3 women, 2 men), ages 27 to 44 (median 33.6) years, who were referred to the Orthopaedic Department outpatient clinic for evaluation of skeletal pain of the humerus, clavicle, sacro-pelvic joints, and distal radius. Data collection and publication was approved by the Institution Ethics Committee. Clinical and radiological evaluation, including X-Rays, CT or MRI scans, and bone scans revealed osteitis and/or hyperostosis in all cases. No patient had skin lesions on initial evaluation, but three of them developed cutaneous manifestations during the assessment and treatment period. Bone biopsy was done in two of five cases.
Before starting treatment, the diagnosis of SAPHO syndrome was established based on the diagnostic criteria proposed by Benhamou et al. [22] . Treatment included non steroid anti-inflammatory medication (lornoxicam) and antibiotics (Clindamycin). Demographic, clinical presentation, treatment and outcome data are summarized in Table 1 .
DESCRIPTION OF CASES

Case 1
A 44-year-old woman suffered from recurrent right mandibular pain for 6 years. During these six years she underwent extensive diagnostic workup, including a negative open mandible biopsy. Due to worsening pain, she had biphosphonate therapy for a year, and underwent local excision of the right mandible lesion twice. After the 2 nd local excision, she was pain-free for 10 days, but then the pain returned. Eighteen months after her 2 nd mandible resection, she was referred to our orthopaedic outpatient clinic, for evaluation of left femur pain. Laboratory workup included ESR, CRP and CBC and was normal. Femur XRays showed one osteosclerotic lesion with cortical thickening and periosteal new bone formation (Fig. 1) the left femur one year later showed that osteosclerosis and hypertrophic osteitis had improved significantly (Fig. 2) . 
Case 2
A 27-year-old woman came to the orthopaedic outpatient clinic for evaluation of localized swelling and tenderness over the right sterno-clavicular joint (Fig. 3 ). There were no signs of infection, and laboratory workup was unremarkable. MRI demonstrated right sterno-clavicular joint hyperostosis changes and bone marrow oedema. Bone scan showed right sterno-clavicular joint and right femur active uptake. X-Rays of the asymptomatic right femur showed hyperostosis in the diaphysis. An open sterno-clavicular joint biopsy was obtained; pathology examination revealed chronic, non-specific inflammatory changes, but all cultures were negative. She was discharged home on Lornoxicam 8 mg p.o. twice a day, but episodes of swelling and pain persisted.
Six months later she returned for re-evaluation, because she developed PPP in her right foot. At that time diagnosis of SAPHO syndrome was established based on the Benhamou et al. criteria (Table 3) . Treatment included oral clindamycin 400 mg three times a day, lornoxicam 8 mg twice/day, and local skin therapy with topical corticosteroids (CSs) and psoralen-ultraviolet A (PUVA). Symptoms improved significantly within 3 months after treatment started. After continuing treatment for eight months, right sterno-clavicular joint swelling and tenderness had disappeared, and treatment stopped. The patient remained symptom-free on her last follow-up visit 4 years later.
Case 3
A 32-year-old man was admitted to the Medicine floor for evaluation of fever of unknown origin, and had orthopaedic surgery consultation for pain at the left distal radius. There were no signs of local infection, and laboratory evaluation was unremarkable, except for moderately elevated ESR (35mm/1 st hour -normal is < 20mm/1 st hour). X-Rays revealed osteitis (osteosclerosis with homogenous fibrillary pattern) of the left distal radius (Fig. 4) , and Technetium 99 bone scan revealed active left distal radius and left sternoclavicular joint uptake. Symptoms improved after NSAID therapy started, and the patient went home one week later.
Two months later, the patient developed right foot acne and returned for re-evaluation. SAPHO syndrome was (Tables 2 and 3) . Treatment with oral Clindamycin 400 mg 3 times a day and Lornoxicam 8 mg twice a day started promptly and continued for 3 months. One year after finishing treatment, the patient was pain-free, without any clinical or laboratory abnormalities. Fig. (4) . Left distal radius sclerosis in a 32 year-old male (case 3).
Case 4
A 31-year-old man was referred to the Orthopaedic outpatient clinic for evaluation of left sacroiliac (SI) joint pain. Physical examination revealed left hand PPP. Laboratory workup was normal, but X-Rays revealed left SI joint osteitis (osteosclerosis with a homogenous fibrillary pattern). Bone scan showed active uptake of the left distal radius and left SI joint.
He was treated for SAPHO with oral Clindamycin 400 mg 3 times a day and Lornoxicam 8 mg twice a day for 3 months. At his last follow-up visit, four months after finishing his treatment course, he remained pain-free and skin lesions have resolved.
Case 5
A 34-year-old woman was evaluated at an outside hospital for right mandible pain lasting several weeks. Laboratory workup (CBC, electrolytes) was unremarkable. X-Rays revealed diffuse right mandible cancellous bone sclerosis with osteolytic lesions and extensive periosteal reaction (Fig. 5) . A mandible biopsy revealed infiltration by inflammatory cells, but no infection or malignancy. She started treatment with oral acetaminophen and NSAIDs, but symptoms persisted. Approximately one year later, she came to our orthopaedic outpatient clinic for evaluation of right femur pain. There were no signs of local infection, and laboratory workup was unremarkable. X-Rays revealed right femur osteitis (osteosclerosis with a homogenous fibrillary pattern). Technetium 99 bone scan showed active right femur and right mandible uptake. SAPHO syndrome was diagnosed, based on the Benhamou criteria ( Table 2) . Treatment consisted of oral Clindamycin 400 mg 3 times a day and Lornoxicam 8 mg twice a day for four months. One year after completing her treatment course, the patient was pain-free and radiologic findings had improved.
DISCUSSION
Clinical Presentation
SAPHO syndrome is a complex disorder, characterized by peculiar combinations of bone lesions and dermatologic manifestations. Patients typically present with musculoskeletal complaints, usually of the anterior chest wall, synovial articulations and synchondroses. In young and middle-aged adults the disease is more common in the sterno-clavicular region (65-90% of patients), but can also affect the spine (33%), pelvis (13-52%) and long bones (30%) [5] , whereas the ilium and mandible are involved in less than 10% of cases [3] . Various articular manifestations, often due to osteitis extending to adjacent articular structures, especially in the sacroiliac and sterno-clavicular joints, may accompany the skin and bone lesions.
Skin involvement includes PPP, severe cystic acne and pustular psoriasis. Skin lesions may precede, occur concurrently or appear after onset of osteoarticular manifestations [3] , but may be initially absent in 1/3 of patients [23] ; consequently, absence of skin lesions does not exclude SAPHO syndrome [24] . The interval between onset of skin manifestations and osteoarticular lesions is generally less than 2 years, but intervals as long as 20 and 38 years have been reported [3, [25] [26] [27] [28] .
Diagnosis
Diagnosis of SAPHO syndrome is based on exclusion of infectious arthritis or osteomyelitis, and the presence of at least one of four diagnostic criteria ( Table 2 ) proposed by Benhamou [22] . Consequently, SAPHO syndrome diagnosis is difficult in patients with a solitary symptomatic bone lesion, because a solitary skeletal lesion can be misdiagnosed as suppurative osteomyelitis, a condition with similar clinical and pathologic findings [14] . Conservative treatment, consisting of antimicrobial therapy and NSAIDs, is generally effective in SAPHO syndrome, without a need for invasive treatments [3, 13, [29] [30] [31] [32] [33] .
In our case series, bony lesions preceded skin manifestations in two cases, bony and skin lesions coexisted in one, whereas two patients had no skin involvement. Initial symptoms involved the sterno-clavicular region in 1 case, long bones in 3, mandible in 2 and SI joint in 1 case. The differential diagnosis includes tumors, infectious arthritis, bacterial osteomyelitis, and Paget's disease.
Laboratory findings are usually of little value, and include mild, non-specific elevation of various inflammatory indices. CRP and ESR are normal or slightly elevated during exacerbations, but white cell count is usually normal. In adults with SAPHO syndrome, prevalence of the HLA-B27 antigen is high, varying between 13% and 30% [2, 3] . Our patients had normal laboratory findings, except for one patient with slightly elevated ESR. HLA-B27 testing was not done in any patient.
Radiologic findings in SAPHO syndrome include osteolysis (Fig. 5), osteitis (Fig. 1) , hyperostosis, and osteosclerosis (Figs. 1, 2) [19] . Osteitis usually presents as osteosclerosis with homogenous fibrillary pattern [3] . Hyperostosis, is highly characteristic of SAPHO, and is characterized by chronic periosteal reaction and cortical thickening, resulting in bone hypertrophy. Joint erosions involving adjacent articulations are frequently seen as result of primary arthritis or extension of adjacent osteitis. CT and MRI are helpful in locating the lesions and providing information on adjacent soft tissues, but cannot distinguish between SAPHO lesions, osteomyelitis and malignancy [34, 35] . Bone scintigraphy is important in diagnosing SAPHO syndrome, particularly for detecting early bone involvement [36] [37] [38] . Lesions appearing in typical sites are important for correct diagnosis. Bone biopsy is often used in an attempt to establish a diagnosis, especially in cases with extra-axial bone lesions, which are particularly prone to radiologic misdiagnosis. Bone lesion histopathology is variable, with early lesions characterized by the presence of polymorphonuclear infiltrate. An intermediate phase is characterized by chronic inflammation (primarily mononuclear cells), whereas lesions with markedly enlarged and sclerotic bone trabeculae and prominent marrow fibrosis are seen in late phases [39] . Propionibacterium acnes, a skin saprophyte, has been isolated from cutaneous lesions with severe acne and from articular and osseous lesions associated with pustulosis. However, most biopsies of involved areas demonstrate nonspecific inflammatory infiltrate [4] , and therefore cannot confirm the diagnosis. In our series, 3 of 5 patients underwent open lesion biopsy, but all biopsies were negative for malignancy, and all cultures were negative for bacteria.
As SAPHO syndrome pathogenesis remains unknown, two hypotheses have been proposed. According to the first hypothesis, bone lesions are caused by a low virulence pathogen transmitted via a blood-borne route. Alternatively an autoimmune response may be triggered by a bacterial or viral pathogen [40] . The second hypothesis suggests a link with sero-negative spondylo-arthropathies, based on the high frequency of axial involvement (sacroiliitis and spinal lesions), asymmetric paravertebral ossification (indistinguishable from ossification encountered in psoriatic spondyloarthropathy) and the possible association with psoriasis and inflammatory bowel (Crohn's and ulcerative colitis) diseases.
Treatment
Treatment options for SAPHO include NSAIDs, antirheumatic drugs, such as colchicine, corticosteroids and biphosphonates, and disease-modifying agents, such as methotrexate, sulfasalazine and infliximab [29] . Biphosphonates, which act by inhibiting bone resorption and turnover [41, 42] , are often used as disease modifiers [15, 42, 43] and anti-inflammatory agents [44, 45] . Antimicrobial therapies are a reasonable choice, since bacteria, such as P acnes [46] and Staph. Aureus [12] have been isolated in specimens from SAPHO patients, and have been implicated in SAPHO pathogenesis. Azithromycin, doxycycline, sulfamethoxazole/ trimetoprim and clindamycin use has been reported in SAPHO [12, 46] . Local treatments, including local corticosteroid injections have also been tried. Dermatologic treatments include topical corticosteroids, tetracycline, other antimicrobial agents, psoralen-ultraviolet A (PUVA) and retinoinds [3] . Among all treatment options listed above, NSAIDS are generally considered as first-line treatment in SAPHO, whereas disease-modifying agents are only indicated when symptoms persist for at least four weeks despite adequate NSAID therapy.
In previous reports, antimicrobials were only given to a minority of cases [3] . Furthermore, a recent study evaluating the role of antibiotic therapy in SAPHO concluded that antibiotic therapy is effective, but SAPHO tends to relapse when antibiotics are discontinued after 16 weeks of treatment [46] . However, our limited experience on five cases suggests that antimicrobial therapy against P. Acnes could be considered first-line therapy, and might help avoid symptom recurrence. We believe that surgery is only indicated when SAPHO-induced changes adversely affect bone mechanics. However, surgery, such as prophylactic intra-medullary nailing, is also a reasonable consideration when bone destruction increases the risk of pathologic fractures. In our case series, only patient #1 had surgery, but this operation was done in an outside hospital, before SAPHO syndrome was diagnosed in our clinic.
Outcome
In our series, after SAPHO syndrome diagnosis was established, all patients promptly received treatment with oral NSAIDs and oral Clindamycin, while patients who developed dermatological manifestations also received topical CSs, and psoralen-ultraviolet A (PUVA). Although biphosphonates were not used, our results were very satisfactory: All patients experienced long-lasting clinical and radiologic improvement after 3-8 months of therapy, and relief persisted during long-term (4 months to 4 years, median 1 year) follow-up.
CONCLUSION
"SAPHO syndrome" is a constellation of musculoskeletal disorders associated with skin conditions. Osteitis is the main skeletal lesion, whereas PPP and acne are important skin lesions. Orthopaedic surgeons should be aware of SAPHO syndrome, and maintain a high level of suspicion, especially when evaluating patients with persistent nonspecific symptoms involving the bone, joints, and/or skin. Prompt SAPHO syndrome recognition, followed by appropriate NSAID and antibiotic therapy will help avoid unnecessary examinations, biopsies and invasive treatments, and may result in long-lasting symptom relief.
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